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Abstract
Lymphoid organ-resident DC subsets are thought to play unique roles in determining the fate of T cell responses. Recent
studies focusing on a single lymphoid organ identified molecular pathways that are differentially operative in each DC
subset and led to the assumption that a given DC subset would more or less exhibit the same genomic and functional
profiles throughout the body. Whether the local milieu in different anatomical sites can also influence the transcriptome of
DC subsets has remained largely unexplored. Here, we interrogated the transcriptional relationships between lymphoid
organ-resident DC subsets from spleen, gut- and skin-draining lymph nodes, and thymus of C57BL/6 mice. For this purpose,
major resident DC subsets including CD4 and CD8 DCs were sorted at high purity and gene expression profiles were
compared using microarray analysis. This investigation revealed that lymphoid organ-resident DC subsets exhibit divergent
genomic programs across lymphoid organs. Interestingly, we also found that transcriptional and biochemical properties of a
given DC subset can differ between lymphoid organs for lymphoid organ-resident DC subsets, but not plasmacytoid DCs,
suggesting that determinants of the tissue milieu program resident DCs for essential site-specific functions.
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Introduction
Dendritic cells (DCs) are present throughout the body and
function as immune sentinels by capturing antigens and detecting
danger signals from their surroundings. This information is then
integrated to either promote T cell immunity or tolerance [1,2,3].
DCs are broadly classified as lymphoid organ-resident or
migratory [2,3]. The major subsets of secondary lymphoid
organ-resident DC in mice include CD8 DCs (CD11c
high
CD11b
2CD8
+CD4
2) and CD8
- DCs that can be further divided
into CD4 DCs (CD11c
highCD11b
+CD8
2CD4
+) and double/triple
negative DCs (CD11c
highCD11b
+/2CD8
2CD4
2) [2,3]. While
CD8, CD4 and CD4
2CD8
2 DCs are resident in all secondary
lymphoid organs, only CD8 DCs are resident in the thymus.
The development of different DC subsets is controlled by
specific transcription factors. For example, CD8 DCs are absent or
reduced in mice lacking IRF8, Id2 and Batf3 [4,5,6] whereas
CD8
2 DCs are absent or reduced in mice deficient for IRF2 and
IRF4 [7,8]. Some of these transcription factors control develop-
ment of additional DC subsets, as IRF8-deficient mice exhibit a
marked reduction in plasmacytoid DCs (pDCs) [6,9], and Batf3-
deficient mice lack the migratory CD103
+ DCs in skin, intestine,
and lung [10]. Beyond developmental differences, important
functional differences have been observed among DC subsets. For
example, even though all DCs efficiently process and present
antigens to T cells, CD8 DCs are specialized for cross-presenting
exogenous antigens via MHC class I to CD8 T cells [11,12,13],
whereas CD8
2 DCs are superior in antigen presentation to CD4
T cells [11]. Furthermore, recent studies using expression profiling
and proteomics demonstrated that a number of gene products
related to antigen presentation are differentially expressed between
CD8 and CD8
2 DCs in the spleen [11,14,15]. The dichotomy
between DC subsets has become widely accepted as a paradigm
for all lymphoid organ-resident DCs. However direct experimental
evidence to support this model and mechanistic data to explain
their functional proclivities are lacking.
Although transcriptional and functional relationships between
various secondary lymphoid organ-resident DC subsets at steady-
state have been described, the relevant studies focused on subsets
isolated from a single lymphoid organ, spleen [11,14,15,16,17].
Phenotypically, spleen and lymph nodes contain the same resident
DC subsets [2,3]. However, each site is physiologically different,
and thus, the individual microenvironment of each site may
influence their development and function. For example, splenic
DCs are exposed to blood-borne molecules, while DCs in
mesenteric lymph nodes are constantly exposed to intestine-
derived antigens and signals. Thus, the genomic association
among DC subsets from different lymphoid organs and possible
differences due to microenvironment-derived factors has remained
enigmatic.
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23921To address this issue, we performed genome-wide expression
analysis, creating a unique transcriptional fingerprint for each
residentDCsubset inspleen,skin-draininglymphnodes,mesenteric
lymph nodes, and thymus of C57BL/6 mice. We successfully
identified and characterized a signature gene expression profile
relevant to majorlymphoid organ-resident DCsubsets, regardlessof
location. This allowed us to create a broadly applicable, subset-
specific schema for division of labor among these subsets in any
lymphoid organ. Strikingly, our analysis also revealed that each
lymphoid tissue may separately imprint their resident DCs with a
characteristic gene expression program, thereby influencing DC
function. Thisheld true even for such similar tissues as skin-draining
and mesenteric lymph nodes, which each imposed distinct trans-
criptional profiles on resident DCs. In addition, thymic CD8 DCs
exhibited high variation compared to CD8 DCs from secondary
lymphoid organs, whereas, pDCs exhibited only minor differences
across secondary lymphoid organs. By comparing and contrasting
resident DCs according to surface phenotype as well as location,
these data represent the largest comparative transcriptional study
of lymphoid organ-resident DCs. Our results reveal a previously
unappreciated level of site-specific specialization among DCs, while
extending current theory regarding lineage relationships between
CD8, CD4 and other DC subsets.
Results
Genomic divergence among CD8 DCs, CD4 DCs and
pDCs spans primary and secondary lymphoid organs
Previous studies, focusing only on spleen, suggested a division of
labor between murine CD8 and CD4 DCs [11,14,15,16,17].
However, it had not been previously determined whether and to
what extent this functional dichotomy existed across multiple
lymphoid organs. To this end, the genome-wide transcriptional
relationships between resident DC subsets from multiple lymphoid
organs were evaluated by sorting CD8 DCs from four sites: spleen,
skin-draining lymph nodes (SLN), gut-draining mesenteric lymph
nodes (MLN) (Figure S1A) and thymus (Figure S1B), and CD4
DCs from three sites: spleen, MLN, and SLN (Figure S1A).
While secondary lymphoid organ-resident DCs represent cells that
complete their differentiation and life history within the microen-
vironment of a single lymphoid organ, pDCs represent cells that
travel from one lymphoid organ to another after their develop-
ment in bone marrow [18]. Therefore, as a comparison, pDCs
were also sorted from spleen, SLN and MLN (Figure S1C). The
gene expression profiles of all DC subsets were analyzed using
Affymetrix mouse Gene ST 1.0 chips.
First, the transcriptional divergence between CD8 DCs, CD4
DCs and pDCs was evaluated using a list of 43 genes represent-
ing subset-associated ‘signature genes’ based on previous reports
[11,14,16,19,20,21]. In spleen, the DC subsets exhibited the
expected gene expression profiles (Figure 1A) as levels of Cd36
and Ly75 (DEC205) were high in CD8 DCs compared to both CD4
DCs and pDCs, whereas those of Clec4a4 (DCIR2) and Clec4a2
(DCIR1) were higher in the CD4 subset. As reported previously,
both CD8 DCs and pDCs expressed high levels of Clec9a (DNGR1)
compared to CD4 DCs whereas Bst2 (PDCA-1), Ccr9 and Klra17
(Ly-49Q) were expressed at high levels exclusively by pDCs
[19,20,21]. Notably, the pattern of subset-associated canonical
gene expression observed in splenic DCs was similar in the
equivalent DCs from MLN and SLN (Figure 1A, and Table S1).
Next, a much broader analysis of gene expression by CD8 DCs,
CD4 DCs and pDCs from different lymphoid organs was carried
out. For this analysis, all 25108 probes (21968 genes) on the chip
were analyzed and those with a fold-change cutoff of .2 in at least
one population compared to any other (coefficient of variance
(CV),0.5 for each, mean expression .120 in at least one
population) were considered to be differentially expressed and
selected for further evaluation. Using these criteria, 6383 probes
(5646 genes) were identified and analyzed by hierarchical
clustering (Figure 1B). Heatmap visualization revealed clusters
of genes enriched in each DC subset across multiple lymphoid
organs. As shown in a fold change plot for spleen, 223 probes (208
genes) were found to be more highly expressed in CD8 DCs
compared to CD4 DCs and pDCs, 232 probes (215 genes) were
more highly expressed in CD4 DCs compared to CD8 DCs and
pDCs, and 872 probes (810 genes) were more highly expressed in
pDCs compared to CD8 DCs and CD4 DCs (Figure 1C, top).
Performing the same analysis for DC subsets from SLN and MLN
indicated that a similar degree of inter-population divergence
existed in those sites (Figure 1C, middle and bottom, black).
To ascertain whether the specific inter-population differences
were shared across secondary lymphoid organs, the differentially
expressed genes identified among splenic DC subsets were
interrogated in the corresponding subsets from SLN and MLN
(Figure 1C, middle and bottom). Of the splenic CD8 DC-
associated probes, ,60–70% were also .2-fold more highly
expressed by CD8 DCs in lymph nodes compared with CD4 DC
and pDC (Figure 1C, red). For CD4 DCs, 45–65% of the splenic
probes were also more highly expressed in the lymph node CD4
DC cohort compared with CD8 DCs or pDCs (Figure 1C,
green). Finally, ,70% of the probes more highly expressed by
splenic pDCs compared with CD8 and CD4 DCs were also
differentially expressed by pDCs from lymph nodes (Figure 1C,
cyan).
As shown in previous studies, genes such as Ly75, Cd86, Tlr3,
and Tlr11 were associated with CD8 DCs, Clec4a4 was associated
with CD4 DCs, Ifnar1/2, Tlr7 and Tlr9 were associated with pDCs
in all secondary lymphoid organs (Table S2). Importantly, a large
number of genes that are new to the field and potentially
important for DC function or development were identified. As
examples, expression levels of the transcription factor Met (HGFR)
and the phosphatase Ppap2a (phosphatidic acid phosphatase type
2A) were higher in CD8 DCs across secondary lymphoid organs
whereas immunoregulatory S100A4 (S100 calcium binding protein
A4), and Nod1 were more highly expressed in CD4 DCs. Genes
such as Duxbl (double homeobox B-like), Havcr1 (Tim-1),
immunoregulatory Sema4b (Semaphorin 4B) and Slamf9 (SLAM
family member 9) were more highly expressed in pDCs across
secondary lymphoid organs. Of note, several of these newly
identified subset-associated genes, such as Met, Duxbl, Ppap2a,
Dscam and Slamf9, were found to be strikingly DC- or myeloid-
specific when compared to key leukocyte populations such as B
cells, T cells and NK cells (Figure S2). Interestingly, flow
cytometry analysis indicated that Tim-1, which is inducible on T
helper 2 cells [22], is expressed exclusively by pDCs in secondary
lymphoid organs at steady-state (Figure 2).
Having identified subset-associated genomic signatures among
secondary lymphoid organ-resident DCs, we next sought to depict
the relationships between DCs that reside in primary and
secondary lymphoid organs. The thymus contains a sizeable
population of CD8 DCs compared with secondary lymphoid
organs (Ref. [23] and Figure S1B) however their precise function
remains to be elucidated. Therefore, comparing the transcriptome
of thymic CD8 DCs with DC subsets in other lymphoid organs
may shed new light on their long sought after function. Because
thymus is largely devoid of CD4 DCs, thymic CD8 DCs were
compared to CD4 DCs and pDCs from spleen. Thymic CD8 DCs
expressed the CD8 DC-associated signature genes in a similar
Divergence among Lymphoid Organ-Resident DCs
PLoS ONE | www.plosone.org 2 August 2011 | Volume 6 | Issue 8 | e23921Figure 1. Genomic divergence between CD8 DCs, CD4 DCs and pDCs across lymphoid organs. (A) Signature gene expression profiles of
CD8 DCs, CD4 DCs and pDCs in spleen (SPL), SLN and MLN, and CD8 DCs in thymus (THY) were analyzed by hierarchical clustering and visualized as a
heatmap. Expression level: red.black.blue. (B) Hierarchical clustering of CD8 DCs, CD4 DCs and pDCs after selection of genes by the following
criteria: .2-fold difference in any combination of populations, coefficient of variation (CV),0.5 for each population, and mean expression .120 for at
least one population. Expression level: red.black.blue. (C) Comparison of gene expression profiles of DC subsets in fold change (x-axis, CD8 vs CD4)
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(Figure 1A). Based on this observation, the probes identified as
splenic CD8 DC-associated in Figure 1C were then used to
compare thymic CD8 DCs with CD4 DCs and pDCs from
secondary lymphoid organs. Consistent with splenic CD8 DCs,
thymic CD8 DCs exhibited a large number of transcriptomic
differences with CD4 DCs and pDCs from all secondary lymphoid
organs (Figure 1D).
Overall, these data indicate that transcriptional divergence
between CD8 DCs, CD4 DCs and pDCs is largely conserved
across primary and secondary lymphoid organs and illuminate
new DC subset-associated genes for future research. Embedded
within these data are the conserved genomic roadmaps that endow
CD8 DCs, CD4 DCs and pDCs with attributes essential to their
core functions across secondary lymphoid organs.
Site-specific transcriptional fingerprints among lymphoid
organ-resident DCs
With the genomic and proteomic profiles of CD8 DCs and CD4
DCs having only been established for spleen [11,14,15,16,17], it
Figure 2. Expression of TIM-1 by pDCs from secondary lymphoid organs. (A) Bar graph showing the expression value of Havcr1 gene for
CD8 DCs, CD4 DCs, DN DCs, TN DCs and pDCs from different lymphoid organs and naı ¨ve NK cells, CD4 T cells, CD8 T cells and B cells from spleen
(data obtained from ImmGen). (B) Various immune cell populations from spleen, SLN and MLN were analyzed for surface Tim-1 expression using flow
cytometry: T and NK cells (gated on mixed CD19
2CD3e
+ cells and CD19
2NK1.1
+ cells), B cells (gated on CD3e
2NK1.1
2CD19
+B220
+ cells), conventional
DCs (gated on CD3e
2CD19
2NK1.1
2B220
2CD11c
high cells), and pDCs (gated on CD3e
2CD19
2NK1.1
2B220
+PDCA-1
+CD11c
low cells). Gray filled, isotype
control; black line, anti-Tim-1. Representative histograms from at least 3 different experiments are shown.
doi:10.1371/journal.pone.0023921.g002
vs fold change (y-axis, CD8 vs pDC) plots. Probes with at least 2-fold difference in expression for one subset compared to the other two in spleen
(top), SLN (middle) and MLN (bottom) are identified (CV,0.5 for each CD8 DC, CD4 DC and pDC population; mean expression .120 in at least one
population). In the spleen, probes that are .2-fold differentially expressed are highlighted in red (CD8 DCs), green (CD4 DCs) and cyan (pDCs). In SLN
and MLN, probes with fold changes .2 are highlighted in black, and probes from the splenic analysis that are also at least 2-fold differentially
expressed in SLN and MLN are highlighted in matching colors. Numbers of probes are indicated on the plots in matching colors. (D) Probes above the
2-fold cutoff associated with thymic CD8 DCs, splenic CD4 DCs and pDCs are shown in black on a fold change (x-axis, CD8 THY vs CD4 SPL) vs fold
change (y-axis, CD8 THY vs pDC SPL) plot. Probes associated with splenic CD8, CD4 DCs and pDCs identified in Figure 1C are highlighted in matching
colors. Numbers of probes are indicated on the plot with matching colors.
doi:10.1371/journal.pone.0023921.g001
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lymphoid organ relates to the same subset residing in another
lymphoid organ. Therefore, we sought to determine whether the
transcriptomic signatures of each resident DC subset were
conserved across lymphoid organs from distant anatomic locales.
The gene expression profiles of CD8 DCs, CD4 DCs or pDCs
were compared in a pair-wise fashion: Spleen vs SLN and MLN,
SLN vs spleen and MLN, and MLN vs spleen and SLN using an
fold-change cutoff value of 2 (CV,0.5 for each, mean expression
.120 in at least one population) (Figure 3A, left). This analysis
pointed to several major outcomes. First, both CD4 and CD8 DCs
exhibited transcriptomic differences specific to location. For
example, 125 probes (89 genes) were more highly expressed by
splenic CD8 DCs compared to their lymph node counterparts,
and 135 probes (113 genes) were more highly expressed by splenic
CD4 DCs compared to the lymph node equivalents (Table S3).
Second, DCs that were resident in SLN and MLN were more
similar to each other than to spleen-resident DCs. For CD4 DCs,
62 probes (60 genes) and 19 probes (19 genes) were associated with
SLN or MLN, respectively, whereas CD8 DCs exhibited few
differences between MLN and SLN (Table S3). Indeed, the
differences between CD4 DCs across secondary lymphoid organs
were greater than the differences between CD8 DCs when probe
numbers were identified by single organ-to-organ comparisons as
tabulated in Figure 3A (right). For example, 2-3x more probes
differed between splenic and SLN CD4 DCs compared to CD8
DCs from spleen and SLN (620 vs 237). Interestingly, and in
contrast to the lymphoid-organ resident DCs, pDC expression
profiles were almost identical across secondary lymphoid organs
(Figure 3A, bottom).
Next we evaluated the degree of similarity among all CD4 and
CD8 DC populations interrogated in this study. As shown in the
correlation matrix, each of the CD4 DC populations were clearly
more similar to one another than to the CD8 DC populations,
however, site-specific variation among each set of populations was
also apparent (Figure 3B). Hierarchical clustering of the
differentially expressed genes shown in Figure 3A revealed clusters
of transcripts that tracked with a single lymphoid organ for CD4
and CD8 DCs (Figure 3C). These belonged to a wide range of
functional groups including inhibitory/activating receptors and
ligands, adhesion and signaling molecules, solute carriers, and ion
transporters. For instance, hmox1, which encodes the immuno-
modulatory enzyme, heme oxygenase I [24], was enriched in
splenic CD8 DCs with ,4-fold higher expression compared to
lymph node CD8 DCs and ,3-fold higher compared to all CD4
DCs (Table S4).
Among the genes expressed by DCs in the MLN is Aldh1a2
(Aldhehyde dehydrogenase 2), also known as retinal dehydroge-
nase 2 (RALDH2). Aldh1a2, with two other enzymes Aldh1a1 and
Aldh1a3, function in retinol metabolism, converting retinal into
retinoic acid (RA) [25]. RA has been implicated in immune
pathways in the gut environment including the imprinting of T
and B cells with intestinal tropism [26,27] and the local generation
of regulatory T cells [28]. Recent studies have suggested that the
RALDHs involved in RA generation are selectively expressed by
CD103
+ intestinal DCs [29] and MLN-resident stromal cells [30].
However, little is known about the role of lymph node-resident DC
subsets in RA generation. The expression levels of Aldh1a1,
Aldh1a2 and Aldh1a3 were compared among CD4, CD8, CD4
2
CD8
2CD11b
+ double negative (DN) and CD4
2CD8
2CD11b
2
triple negative (TN) DCs (sorting strategy in Figure S1A) as well
as CD8 DCs from thymus, and pDCs from spleen, SLN and
MLN. The signal for Aldh1a2 was detected in all DC populations
from MLN except pDCs, and expressed in DN DCs from SLN
(Figure 4A, gray bars). However, Aldh1a1 and Aldh1a3 were not
expressed by any DCs subset studied here (Figure 4A, white and
black bars). Next, the flow cytometry-based Aldefluor assay was
used to determine whether the Aldh1a2 enzyme was active in
these DC subsets. Given that Aldh1a1 and Aldh1a3 are not
expressed by DCs, any enzyme activity detected in this assay
would be attributable to Aldh1a2. Little or no enzyme activity was
detected in splenic and SLN-resident DC subsets whereas CD4,
CD8 and CD4
2CD8
2 DCs from MLN were Aldefluor
+
(Figure 4B and C). There was a tight correlation between
Aldh1a2 gene expression levels (Figure 4A) and the proportion of
Aldefluor
+ DCs (Figure 4C). Taken together, our results
demonstrate that all subsets of conventional DCs in MLNs but
not pDCs express Aldh1a2 and functional Aldh1a2 enzyme. That
multiple conventional DC subsets in a given secondary lymphoid
organ can display identical site-specific functions at both the
transcriptional and protein levels whereas pDCs exhibit relatively
few site-specific differences suggests that conventional DCs are
more prone to programming by their immediate surroundings, at
least under steady state conditions. Programming of DC function
by microenvironmental cues might ensure tasks critical for the
particular anatomical site in which they reside.
Significant divergence between thymic and secondary
lymphoid organ-resident CD8 DCs
Given the variation observed in gene expression among spleen
and lymph node-resident CD8 DCs, we next sought to determine
whether a similar degree of divergence existed between CD8 DCs
from primary and secondary lymphoid organs. From the heatmap
in Figure 1B, it was evident that clusters of genes were enriched in
thymic CD8 DCs compared with secondary lymphoid organ-
resident CD8 DCs. To evaluate this further, a direct comparison
of the genome-wide expression profiles of thymic CD8 DCs with
secondary lymphoid organ-resident CD8 DCs was performed.
The transcriptomic relationship between the thymic and splenic
CD8 DCs was then examined by analyzing the distribution of
differentially expressed genes on a fold change vs t-test P value
plot. Using a 2-fold cutoff (CV,0.5 for each, mean expression
.120 for at least one population), 795 probes (725 genes) were
found to be more highly expressed by thymic CD8 DCs compared
with splenic CD8 DCs (Figure 5A and Table S5). On the other
hand, 97 probes (95 genes) were associated with splenic CD8 DCs
compared with their thymic counterparts (Figure 5A and Table
S5). When, thymic CD8 DCs were compared to lymph node CD8
DCs, we found that 967 probes (803 genes) were more highly
expressed by thymic CD8 DCs, whereas 36 probes (34 genes) were
associated with lymph node CD8 DCs compared to thymic CD8
DCs (Figure 5B, black). Next, the relative expression pattern of
those genes differentially expressed among thymic and splenic
CD8 DCs was evaluated in the corresponding subsets from SLN
and MLN (Figure 5B) using a fold change (thymus vs SLN) vs
fold change plot (thymus vs MLN). We found that 545 of the 795
probes (537 genes) were also more highly expressed by thymic
CD8 DCs compared with CD8 DCs from lymph nodes
(Figure 5B, red) whereas, 13 out of 97 probes (13 genes) were
more highly expressed in CD8 DCs from both lymph nodes
compared to thymic CD8 DCs (Figure 5B, green).
These results demonstrated that a large number of genes are
more highly expressed by thymic CD8 DCs compared to their
counterpart in secondary lymphoid organs. This is further
supported by data shown in the correlation matrix, which
indicates that CD8 DCs in secondary lymphoid organs are more
similar to one another than to their thymic counterparts
(Figure 5C). In sum, our analysis of thymus- and secondary
Divergence among Lymphoid Organ-Resident DCs
PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e23921Figure 3. Identification of secondary lymphoid organ-specific differences among DCs subsets. (A) Left, Gene expression profiles of CD8
DCs (top), CD4 DCs (middle) and pDCs (bottom) in the spleen, SLN and MLN were compared and probes above the 2-fold cutoff in one organ
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transcriptional signature for CD8 DCs but also illuminates
hitherto unrecognized differences in gene expression between
lymphoid microenvironments.
Subset and location shape transcriptional fingerprints of
lymphoid organ-resident DCs
Next, the relative transcriptomic relationships between CD8
DCs, CD4 DCs and pDCs with respect to other DCs subsets
across primary and secondary lymphoid organs were evaluated.
To this end, principal component analysis (PCA) was used to
measure of population distance based on inter-subset variation
(Figure 6). In this analysis, we included DN and TN DCs from
spleen (resident DCs), SLN and MLN (mixture of resident and
migratory DCs), CD4, CD8 and pDCs from secondary lymphoid
organs, and CD8 DCs from thymus, and individual replicates for
each population were plotted. The largest variation measured
among the subsets existed between pDCs and conventional DCs.
pDCs across secondary lymphoid organs clustered tightly,
indicating high level of similarities in their transcriptional profile
regardless of location. Conventional DCs were characterized by
distinct clusters: CD8 DCs from secondary lymphoid organs and
thymus, CD4 DCs from secondary lymphoid organs closely
associated with DN/TN DCs from spleen, and finally, migratory
DC-rich DN/TN DCs from lymph nodes. Consistent with our
results, the PCA also measured significant intra-population
differences for all subsets except pDCs, though these were smaller
than the inter-population distances. Thus, the relative distance
between DC subsets supports the notion that lymphoid organ-
resident DCs and pDCs, as well as DN and TN DCs, differ rather
distinctly from each other at the transcriptomic level.
Discussion
Conventional DCs are dedicated antigen presenting cells that
orchestrate T cell responses [2,3]. Compared with other leukocytes,
DCs are specialized for efficient antigen capture, processing and
presentation. Likewise, they are armed with a variety of receptors
that allows them to survey their microenvironment and integrate
inflammatory cues including pathogen and damage associated
signals [31]. Emerging studies suggest that DC subsets of distinct
developmental origin cooperate with one another in a functional
sense but carry out different aspects of adaptive immunity. Among
lymphoid-organ DCs, division of labor has been analyzed most
extensively, using transcriptional profiling and proteomic assays, in
splenic CD8 and CD8
2 DCs due to their abundance and
accessibility [11,14,15,16]. Other studies focused on the relative
role of resident and migratory DC subsets in T cell responses using
mainly functional assay [10,32,33,34,35,36]. Observations from
these studies raised the possibility that subset-specific molecular
programs might account for their unique roles in adaptive
immunity. However, definitive evidence to explain how individual
DC subsets from different lymphoid organs function and contribute
to host defense and tolerance is still lacking.
To date, it is assumed that the function of a given DC subset is
dictated by developmental specifications and that DCs belonging
to a given subset would more or less exhibit the same genomic and
functional programs throughout the body. Here, we interrogated
the transcriptional relationships between lymphoid organ-resident
DC subsets, particularly CD8 and CD4 DCs, from multiple sites
including primary and secondary lymphoid organs. This investi-
gation allowed us to 1) define genomic programs that distinguish
lymphoid organ-resident DC subsets from one another throughout
the body and 2) identify transcriptional and functional properties
of a given lymphoid organ-resident DC subset that vary between
anatomical locations. We confirmed the inter- and intra-subset
genomic relationships by hierarchical clustering as well as by
detailed comparisons of genomic and functional characteristics of
the relevant DCs.
The multiple lymphoid organ approach to compare gene
expression profiles of CD8 and CD4 DC allowed us to identify
subset-associated transcriptional and functional programs that
support the notion of a division of labor. Previous gene expression
studies had identified differences between CD8 and CD4 DCs
primarily in the spleen [11,14,15,16]. Differential expression of C-
type lectins such as DEC205 and DCIR2 by CD8 and CD8
2
DCs, respectively, are well-known examples [11]. Antigen delivery
studies targeting these receptors suggest functional bias of CD8
DCs towards CD8 T cells and CD8
2 DCs towards CD4 T cells.
Furthermore, compared to CD4 DCs, CD8 DCs exhibit a
transcriptional program that is characterized by genes biased
towards CD8 T cell responses such as MHC class I-related
molecules, IL-12, IL-15 and XCR1 [11,37,38,39,40]. Our study
built an extensive expression profile for CD4 and CD8 DCs
consisting of numerous genes that differ between the two subsets
across different lymphoid organs. Importantly, we identified novel
gene targets critical for various cellular and molecular processes of
DCs that have not been previously studied including solute
carriers, immunomodulatory and signaling molecules such as
transcription factors, kinases, phosphatases.
When the gene expression profile of a given DC subset is
compared across multiple lymphoid organs, marked site-associated
differences are observed. It is unclear why such differences exist
but several plausible explanations can be surmised. One possibility
is that the genomic program of DCs is influenced by the organ in
which it resides. In that sense, determinants of the local tissue
milieu might significantly impact gene expression and downstream
function of DCs. Programming of gene expression by the
microenvironment could result in a tissue-associated signature
reflected in all DCs living in the vicinity. The expression of
aldehyde dehydrogenase 2 by resident and migratory DC subsets
in MLNs is an example of such a tissue-associated signature.
Previous studies showed that particularly migratory DCs in the gut
use this enzyme for imprinting T cells [29]. Consistent with this,
we observed the higher level of expression and enzyme activity in
double/triple negative DCs that contain high proportion of
migratory DCs. Interestingly, this tissue-associated expression
pattern is also observed among non-hematopoietic stromal cells
that reside in MLNs [30]. Currently it is unclear how MLN DCs
are programmed to express this enzyme, although dietary agents
including vitamin A have been implicated [41]. After their
development from common progenitors in the bone marrow, DCs
compared to the other two are highlighted on fold change (x-axis, SPL vs SLN) vs fold change (y-axis, SPL vs MLN) plots. Numbers of probes are
indicated on the plots. Right, numbers of probes above 2-fold difference in expression for organ pairs are summarized in tables for CD8 DCs (top),
CD4 DCs (middle) and pDCs (bottom). Probe selection criteria: CV,0.5 in each population of a given subset, mean expression .120 for at least one
population of a given subset. Red, SPL .SLN and MLN; blue, SLN.SPL and MLN; black, MLN.SPL and SLN. (B) Correlation matrix comparison of CD8
DCs and CD4 DCs across the spleen, SLN and MLN. Numbers indicate correlation coefficient. (C) A dataset including all the genes identified in
Figure 3A for CD8 and CD4 DCs are analyzed by hierarchical clustering and illustrated using a heatmap. Expression level: red.black.blue.
doi:10.1371/journal.pone.0023921.g003
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specific programming mediated by soluble factors derived from the
intestine and/or lymphoid stroma. Whether microenvironment-
specific programming of gene expression is evident in other
immune cells remains to be determined.
Global analysis as well as subset-to-subset analysis indicated that
DCs residing in lymph nodes are clustered together and relatively
distant from their counterparts in spleen. This may be due to tissue-
specific programming of splenic DC subsets by the metabolite-rich
contents of the blood. Interestingly, we found larger differences
amongCD4DCsindifferentsecondarylymphoidorganscompared
to the differences in CD8 DCs. One explanation may be that CD4
DCs are more responsive to microenvironmental cues due to their
biochemical makeup or their proximity to such signals. Another
explanation may be that splenic CD4 DCs are more heterogenous
compared to their counterparts in lymph nodes. We also compared
CD4
2CD8
2 DCs to other DC lymphoid organ resident subsets.
We found that splenic CD4 and CD4
2CD8
2 DCs are very similar
to one another in terms of gene expression profiles. This close
relationship was also suggested by previous reports [14,15] and here
we confirmed this via global analysis of their transcriptomes. On the
other hand, CD4
2CD8
2 DCs from the lymph nodes clustered
separately compared to all resident DC subsets. This may be
associated with the heterogeneity of CD4
2CD8
2 populations in
lymph nodes due to the presence of various migratory DC subsets
[2,3]. The developmental and functional differences of pDCs
comparedtoconventionalDCsisalsoreflectedinthe global analysis
inwhich pDCswere themost distant toanyotherDCsubset studied
here. In addition, the differences in gene expression profiles among
pDCs from different secondary lymphoid organs were minimal
compared to conventional DCs. Unlike conventional DCs that
reside in lymphoid or non-lymphoid organs, pDCs develop in bone
marrow and circulate throughout lymphoid organs via blood [18].
The developmental stage when they are exposed to different
lymphoid organs and the transit time through each lymphoid organ
may not be suitable to influence their transcriptome.
While the importance of CD8 DCs in cross-presentation of
antigens to CD8 T cells in secondary lymphoid organs is well
studied and appreciated, their role in the thymus remains unclear.
The composition of thymic DCs is markedly different from DCs in
secondary lymphoid organs. The proportion of CD8 DCs is
relatively low in secondary lymphoid organs, representing 10–25%
of all DCs (Ref. [2,3] and this study). In the thymus, however,
three DC populations, resident CD8 DCs, migratory CD8
2Sirpa
+
DCs and pDCs, have been identified and a large portion of these
cells is comprised of CD8 DCs (,50–90%) (Ref. [23] and this
study). The large contingent of CD8 DCs in this organ suggests
that they play an important role in thymic processes. CD8
2Sirpa
+
DCs have recently been implicated in thymic selection since these
migratory cells can capture and carry peripheral tissue antigens to
Figure 4. Aldh1a2 expression is a shared property among DC
subsets in MLNs. (A) Mean expression values for Aldh1a1 (white),
Aldh1a2 (gray) and Aldh1a3 (black) genes by CD4, CD8,
CD4
2CD8
2CD11b
+ double negative (DN), CD4
2CD8
2CD11b
2 triple
negative (TN) DCs and pDCs in secondary lymphoid organs and CD8
DCs in the thymus. (B) Representative histograms showing aldehyde
dehydrogenase activity based on Aldefluor staining in DC subsets.
Numbers indicate the percentage of Aldefluor
+ cells. Black line,
Aldefluor staining; gray-filled, Aldefluor staining in the presence of
the aldhehyde dehydrogenase inhibitor DEAB. (C) Bar graphs showing
the percentage of Aldefluor
+ DCs in secondary lymphoid organs. Data
are representative of 3–4 independent experiments. ** indicates
P,0.01. Data are represented as mean+SD.
doi:10.1371/journal.pone.0023921.g004
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resident CD8 DCs have such roles in the T cell selection process.
Several studies suggest that CD8 DCs in SLN can acquire viral
antigens carried by migratory DCs and present these antigens to
CD8 T cells [34,42]. Therefore, there may be a similar interaction
between thymic CD8 DCs and migratory Sirpa
+ DCs in terms of
antigen presentation.
Although all CD8 DCs have a common transcriptional program
reflecting their function, both global and organ-to-organ analyses
indicated that thymic CD8 DCs are distant from their counterparts
in secondary lymphoid organs. Among these differences, expression
of a variety of endocytic receptors including at higher levels was
observed. CD8 DCs are highly efficient at capturing apoptotic cells
and cross-presenting antigens associated with these cells [43,44].
Although the receptors involved in apoptotic cell capture by CD8
DCs are yet to be identified, receptors such as DEC205, Clec9A,
CD36 and Treml4 [16,20,45,46,47,48] may be involved. Overall,
CD8 DCs in the thymus are equipped with a variety of endocytic
receptor compared to both CD4 and CD8 DCs in secondary
lymphoid organs suggesting that these cells may be heavily involved
in clearance of apoptotic cells, particularly T cells that failed
selection. The divergence in transcriptional profiles between CD8
DCs in thymus and secondary lymphoid organs may be explained
by the differences in their developmental origin. Thymic CD8 DCs
reside in a structurally different organ that is not known to have a
peripheral sentinel function as lymph nodes or spleen. Importantly,
while the majority of DCs arise from a myeloid progenitor [18],
thymic CD8 DCs as well as pDCs are thought to be derived from
lymphoid lineages and may carry traces of pre-T cell genes [49].
A unique aspect of our study was the use of a strict experimental
procedure implemented by the multi-institute collaboration known
as the Immunological Genome Project (ImmGen). We utilized the
highly standardized protocol established by ImmGen which strives
to minimize sample variation between participating laboratories
by employing common reagents, limited processing times,
centralized RNA handling, and stringent normalization and
quality control measures (Ref. [50] and www.immgen.org). This
has proven to be a powerful and precise approach for examining
transcriptional relationships among more than 200 murine
leukocyte subsets and hematopoietic progenitors. Furthermore,
similar approaches are currently being taken to systematically
evaluate the relationships between mouse and human leukocytes.
In conclusion, this study has illuminated novel transcriptional
relationships among major lymphoid organ-resident DC subsets.
DCs function as decision makers for T cell responses. DC subsets
exhibit differences in the ways they detect signals from their
surroundings and interact with different T cell subsets. Therefore,
elucidating how each DC subset functions is essential to understand
how they promote T cell tolerance and immunity. This is the first
study to demonstrate site- and subset-associated relationships
between lymphoid-organ resident DCs. We showed that while
DCs exhibit transcriptional programs that correlate with their
developmental origin and phenotypic subset, anatomical location
promotes divergence from this program to adjust for functions
associated with the microenvironment. Global analysis of these cells
relative to multiple immune cell subsets in the ImmGen Project will
further provide new dimensions to our understanding of the
immune system. This knowledge will be invaluable for identifying
novel targets and developing efficacious immunotherapeutics.
Materials and Methods
Ethics statement
All animal work has been carried out in accordance with US
National Institutes of Health guidelines. This study is reviewed and
approved by the Dana Farber Cancer Institute, Animal Care and
Use Committee (ACUC) (protocol IDs: 04-025 and 07–038).
Figure 5. Comparison of gene expression profiles of CD8 DCs
in the thymus and secondary lymphoid organs. (A) Fold change
(x-axis, CD8 THY vs SPL) vs T-test P value (log10, y-axis, CD8 THY vs SPL)
plot showing the number of probes with a difference in expression of at
least2-fold(CV,0.5 foreachCD8population; expression.120 for atleast
one population). Red, CD8 THY.SPL; green, CD8 SPL.THY. (B) Gene
expressionprofileofCD8DCsinthethymuscomparedwithSLNandMLN.
.2-fold differentiallyexpressedprobes in the thymusrelative tobothSLN
andMLNarehighlighted ona fold change (x-axis,CD8 THY vs CD8 SLN)vs
fold change (y-axis, CD8 THY vs CD8 MLN) plot. Probes identified in
Figure 5A that remain above the 2-fold cutoff in these other sites are
highlighted in matching colors. Numbers of probes are indicated on the
plot in matching colors. (C) Correlation matrix for CD8 DCs across the
thymus, spleen, SLN and MLN. Numbers indicate correlation coefficient.
doi:10.1371/journal.pone.0023921.g005
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Male C57BL/6 mice of 6 weeks of age were purchased from
The Jackson Laboratories. Animals were maintained under
pathogen free condition in the Animal Facility of the Dana-
Farber Cancer Institute.
Cell preparation, sorting and flow cytometry
For each DC sorting, tissues from at least 3 mice were pooled.
Spleen, SLN, MLN or thymus were gently disrupted by forceps
and incubated for 15 min at 37uC in phenol-red free DMEM
(Mediatech) containing 10 mM HEPES, 0.1 mg/ml DNase I
(Invitrogen) and 0.28 U/ml Liberase Blendzyme III/DL (collage-
nase/neutral protease with very low to negligible levels of
endotoxin, Roche). Single cell suspensions were subjected to
RBC-lysis using ACK buffer (Lonza Biowhittaker) and transferred
into depletion buffer (PBS, 2 mM EDTA and 2% FBS) containing
FcR-blocking antibody (2.4G2, produced in house). CD19, CD3e,
Gr1, NK1.1 and TER-119 positive cells were depleted using anti-
biotin MACS beads (Miltenyi). Cells were stained in FACS buffer
with combinations of fluorochrome-conjugated antibodies against
CD11b (M1/70), CD4 (L3T4), CD11c (N418), CD8 (53–6.7) from
eBioscience, and I-A/I-E (M5/114.15.2) from Biolegend. Propi-
dium iodide (Sigma Aldrich) was used to exclude dead cells. Cells
were sorted using a BD FACS Aria (70 mm nozzle, 50 psi, BD
Biosciences). After an initial sort to verify purity, a second sort was
performed to collect DC populations of 95–100% purity directly
into TRIzol reagent (Invitrogen). Sample size for each DC
population is as follows: CD4 DCs, n=5 in spleen, n=3 in SLN,
n=3 in MLN; CD8 DCs, n=5 in spleen, n=3 in SLN, n=3 in
MLN, n=3 in thymus; pDCs, n=3 in spleen, n=3 in SLN, n=2
in MLN; CD4
2CD8
2CD11b
+ double negative (DN) DCs n=3 in
spleen, n=3 in SLN, n=3 in MLN; CD4
2CD8
2CD11b
2 triple
negative (TN) DCs, n=3 in spleen, n=4 in SLN, n=5 in MLN.
For flow cytometry analysis, cells were stained in FACS buffer
containing FcR-block antibody (2.4G2) with combinations of
fluorochrome-conjugated or biotinylated antibodies against
CD11b (M1/70), CD4 (L3T4), CD11c (N418), CD8 (53-6.7),
CD45 (30.F11), Gr1 (RB6-8C5), CD3e (145-2C11), NK1.1
(PK136) CD19 (MB19-1), PDCA-1 (eBio927), Tim-1 (RMT1-4)
and B220 (RA3-6B2) from eBioscience. Cells were analyzed using
a BD FACS Aria and phenotypes were analyzed using FlowJo
Software (Tree Star, Inc).
Detection of aldehyde dehydrogenase activity
Aldehyde dehydrogenase activity was tested using the Aldefluor
assay kit (StemCell Technologies) as described in the manufactur-
er’s protocol with some modifications (100 mM of DEAB reagent
(Sigma) and 300 nM of the Aldefluor reagent). Aldefluor
incubation was followed directly by surface marker staining and
flow cytometric analysis.
Figure 6. Global relationships among major subsets of lymphoid organ-resident DCs. Principal component analysis comparing DC
subsets from different lymphoid organs. Percentages reflect the total variation among populations in each principal component (PC). Each circle in
the 3D plot indicates a replicate for the 16 DC subsets. Lines indicate the coordinates of one representative replicate for each subset on PC1 and PC2.
doi:10.1371/journal.pone.0023921.g006
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Total RNA was prepared using chloroform extraction accord-
ing to manufacturer’s protocol, and 100 ng of RNA from each
sample was used for amplification, labeling, and hybridization by
Expression Analysis, Inc. (Durham, NC). Mouse Gene ST 1.0
chips (Affymetrix) were used for microarray analysis. All data is
MIAME compliant and the raw data for the Immunological
Genome Project (ImmGen) including dendritic cells analyzed in
this study have been deposited in a MIAME compliant database
[NCBI Gene Expression Omnibus (GEO) data repository; record
no: GSE15907].
Various modules included in the GenePattern platform (Broad
Institute) were used for data analysis. Raw data were normalized
using the ExpressionFileCreator module (RMA method). The
MultiPlot module was used for dataset comparisons including fold
change analysis and statistical filtering. In each analysis, we
preprocessed the dataset for the populations included in specific
analyses. The first criterion was to select probes with mean
expression value greater than 120, which gives real signal with
95% confidence. We selected all probes with mean expression
above 120 in at least one of the populations analyzed (exceptions:
163 for CD4 MLN, 175 for CD4 SLN, 153 for CD8 SLN, 150 for
CD8 SPL, 149 for DN MLN, 172 for DN SPL, and 170 for TN
MLN. For simplicity, the value was stated as ‘‘120’’ in the Results
and Figure Legends). This filter was used in combination with
coefficient of variation (CV),0.5 for replicates. In all fold change
analyses, an arbitrary cutoff value of 2 was used. T-test P values for
each probe for .2-fold differences in expression were indicated in
supplementary tables and P,0.05 was considered statistically
significant. For hierarchical clustering, Spearman’s correlation was
used with datasets following log2 transformation, row centering
(subtraction of the mean of each row), and row normalization (sum
of the squares of the values in each row is 1.0) in the
HierarchicalClustering module. Heatmaps were constructed using
the HeatmapViewer module. Correlation matrices were con-
structed after preprocessing datasets using the Expression Matrix
module created by ImmGen. Dataset for the specific subsets that
are analyzed were first filtered for probes with expression .120 for
at least one population, CV,0.5 for each population and fold
difference .2 for at least two populations. Data was further
preprocessed as described for hierarchical clustering. Principal
component analyses were done using the PopulationDistances
module created by ImmGen. In this analysis, 16 DC subsets were
included. First probes with mean expression value .120 were
selected, then dataset was log2 transformed row centered
(subtraction of the mean of each row), and column centered
(division by standard deviation). PCA was computed on the 15%
most differentially expressed genes among subsets. In principal
component analysis, the first principal component represents
38.06% variation, second principal component represents 23.95%
variation, and the third principal component represents 16.17%
variation. The purity of sorted samples was validated by
comparing expression values of various genes (Cd4, Cd8a, Itgam,
Itgax, Itga2, Ncr1, Klrb1c, Cd3e, Cd247, Cd8b, Cd19, Cd79a, Siglech,
Ly6g and Ly6c) to other immune cell subsets included in the
ImmGen dataset (Ref. [50] data not shown).
Statistical analysis for non-microarray data
Data in bar graphs are presented as the mean6SD and were
analyzed using the one-tailed, unpaired Student’s T-test for
comparison of two groups. P values ,0.05 were considered
statistically significant.
Supporting Information
Figure S1 Strategy for sorting DC subsets from primary
and secondary lymphoid organs. For high purity sorting,
conventional DCs were sorted from CD3e/CD19/NK1.1/Gr1/
Ter119-depleted cells, while pDCs were sorted from CD3e/
CD19/NK1.1/Ter119-depleted cells. (A) Representative plots
showing the gating strategy used for sorting and post-sort purity
analysis of CD4 (CD11c
hiCD11b
+CD4
+CD8
2, n=5 in SPL, n=3
in SLN, n=3 in MLN), CD8 (CD11c
hiCD11b
2CD4
2CD8
+,
n=5 in SPL, n=3 in SLN, n=3 in MLN), CD4
2CD8
2CD11b
+
(CD11c
hiCD11b
+CD4
2CD8
2, n=3 in SPL, n=3 in SLN, n=3
in MLN) double negative (DN) DCs, and CD4
2CD8
2CD11b
2
(CD11c
hiCD11b
2CD4
2CD8
2, n=3 in SPL, n=4 in SLN, n=5
in MLN) triple negative (TN) DCs from the SPL (top), SLN
(middle) and MLN (bottom). (B) Representative plots showing the
gating strategy used for sorting and post-sort purity analysis of
thymic CD8 DCs (MHC-II
hiCD11c
hiCD8
+CD11b
2, n=3). (C)
Representative plots showing the gating strategy used for sorting
and post-sort purity analysis of pDCs (CD11c
intB220
+Gr1
+CD8
+,
n=3 in SPL, n=3 in SLN, n=2 in MLN) from the SPL (top),
SLN (middle) and MLN (bottom).
(TIF)
Figure S2 Expression values of various genes associated
with DCs and myeloid cells. Bar graphs showing the
expression value of Met, Ppap2a, Dscam, Duxbl and Slamf9 for
CD8 DCs, CD4 DCs, DN DCs, TN DCs and pDCs from different
lymphoid organs and naı ¨ve NK cells, CD4 T cells, CD8 T cells
and B cells from spleen (data obtained from ImmGen).
(TIF)
Table S1 Canonical gene expression profile of CD8
DCs, CD4 DCs and pDCs across lymphoid organs.
(XLS)
Table S2 Probes associated with CD8 DCs, CD4 DCs or
pDCs across lymphoid organs; gene list based on 2-fold
change in one subset compared to the other two in
spleen.
(XLS)
Table S3 Probes associated with CD8 DCs, CD4 DCs or
pDCs in a given lymphoid organ.
(XLS)
Table S4 Combination of genes identified in CD8 and
CD4 DCs across lymphoid organs ordered according to
hierarchical clustering in heatmap.
(XLS)
Table S5 Comparison of CD8 DCs across secondary
lymphoid organs (SLO) based on thymus and spleen
associated probes.
(XLS)
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